Givaudan SA (GIVN.SW) stock: key figures, P/E, revenue and dividend
Materials · Switzerland · ISIN CH0010645932
Givaudan SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 7.41 bn CHF | 7.47 bn CHF |
| Gross profit | 3.27 bn CHF | 3.25 bn CHF |
| Operating income | 1.40 bn CHF | 1.37 bn CHF |
| EBIT | 1.39 bn CHF | 1.38 bn CHF |
| Net income | 1.09 bn CHF | 1.07 bn CHF |
| Diluted EPS – continuing operations | 117.53 CHF | 115.52 CHF |
Full history since 1997, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Givaudan SA
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, and alcoholic drinks; dairy and cheese products, including dairy drinks, yoghurt, ice cream, chilled desserts, cream cheese, and spreads; snacks; givaudan flavour ingredients; savory, and supplements and nutraceutical products; and biscuits, crackers, and cereals, as well as confectionery products, such as chewing gums, chocolates, and sweets. It operates in Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. Givaudan SA was founded in 1796 and is headquartered in Vernier, Switzerland.
More stocks
- NetApp (NTAP)
- Ventas (VTR)
- Haleon PLC (HLN.L)
- Ferguson Enterprises (FERG)
- Exelon (EXC)
- Holcim AG (HOLN.SW)
- Waters Corporation (WAT)
- East Money Information Co Ltd (300059.SZ)
- Aena SME SA (AENA.MC)
- Dr Ing hc F Porsche (P911.DE)
- HEICO CORP (HEI)
- Samsung Biologics Co Ltd (207940.KS)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.